Indo-MIM

Indo-MIM

LISTED

IPO Date: 23 Jul - 27 Jul 2026

Listing Date: 30 Jul 2026

Price Range

Rs.461 - Rs.485

Issue Size

3811 Cr

Min Investment

₹13,830

Min Application

30 Shares

Schedule of Indo-MIM

Issue open date

23 Jul 2026

Issue close date

27 Jul 2026

UPI mandate deadline

27 Jul 2026 (5 PM)

Allotment finalization

28 Jul 2026

Share credit

29 Jul 2026

Listing date

30 Jul 2026

Mandate end date

11 Aug 2026

Issue size

Funds Raised in the IPOAmount
Overall3811 Cr
Fresh Issue499.1 Cr
Offer for Sale3311.21 Cr

Allotment DetailsNew

Allotment TimelineDetails
Allotment Date28 Jul 2026
Allotment Link{Link}

Grey Market Premium

New

Grey Market Premium (GMP) is the premium at which the shares are traded in the grey market. It gives a fair idea about the listing price of the IPO shares. The GMP can be positive or negative based on the demand and supply of the shares in the grey market.

DateIPO PriceGMPEst. Listing Price
30 Jul 2026Latest₹485₹184669(+37.94%)
29 Jul 2026₹485₹186671(+38.35%)
26 Jul 2026₹485₹190675(+39.18%)
25 Jul 2026₹485₹181666(+37.32%)
24 Jul 2026₹485₹184669(+37.94%)
22 Jul 2026₹485₹185670(+38.14%)
21 Jul 2026₹485₹194679(+40%)
20 Jul 2026₹485₹195680(+40.21%)
19 Jul 2026₹485₹0485(0%)
18 Jul 2026₹485₹0485(0%)

Performance Indo-MIM

Issue PriceListing GainCurrent Market PriceP/L
Rs.461 - Rs.485 700 (44.33%) 988.1103.73%

About Indo-MIM

Indo-MIM Limited is a precision engineering company that manufactures components using metal injection molding (MIM) technology. The company provides end-to-end manufacturing solutions, including mold design, tooling, finishing, and assembly. In addition to MIM, it also uses investment casting, precision machining, ceramic injection molding, and metal 3D printing to manufacture components. Its products serve the automotive, defence, medical, consumer, and aerospace sectors, with applications ranging from vehicle safety systems and firearm components to surgical devices, aerospace parts, and consumer products. During FY26, the company manufactured over 9,000 product types. As of March 31, 2026, Indo-MIM operated 15 manufacturing facilities, including six in India, six in the United States, two in the United Kingdom, and one in Mexico. The company also has sales offices in China, Germany, and the United States, serving customers across North America, Europe, and Southeast Asia. Use of proceeds: The IPO consists of both a fresh issue and an offer for sale (OFS).​ Net proceeds from the OFS will go to the respective selling shareholders, while the net proceeds from the fresh issue will be utilised for the following purposes:​ Repayment/ prepayment, in full or part, of all or certain outstanding borrowings availed by the company — Rs 400 crore General corporate purposes

Founded in1996
Managing directorMr Krishna Chivukula
Parent organization

Financial Overview

Strengths

5
  1. 1

    INDO-MIM is a leading global provider of precision engineering components utilising metal injection molding technology.

  2. 2

    The company operates fifteen manufacturing facilities across India, the United States, the United Kingdom, and Mexico.

  3. 3

    The company offers end-to-end capabilities ranging from mold designing and tooling to finishing, assembly, and in-house stainless steel powder manufacturing.

  4. 4

    The business is diversified across major end-use industries including automotive, defence, medical, consumer products, and aerospace sectors.

  5. 5

    The company has a global customer footprint with long-standing relationships and exports to markets across North America, Europe, and Asia.

Risks

5
  1. 1

    The company derives a significant portion of its revenue from its top 10 customers.

  2. 2

    A major portion of revenue from operations is generated from exports to foreign jurisdictions.

  3. 3

    The company generally operates on a purchase order basis without long-term binding supply commitments from customers.

  4. 4

    The company relies on key international suppliers and imports a significant portion of its raw material requirements.

  5. 5

    Promoters, directors, and key managerial personnel have received show-cause notices regarding alleged non-compliance with cost auditor appointment rules.

Subscription Figures

CategorySubscription (No. of times)
Qualified Institutional Buyers (QIBs)204.47
Non-Institutional Investors (NIIs)50.65
Retail Individual Investors (RIIs)6.69
Employee9.44
Total72.37